Heart Failure Mortality Reduced with Relaxin

A recent study with heart failure patients with above normal blood pressure showed that introducing the naturally-occurring hormone Relaxin reduced mortality and shortness of breath.  Relaxin is naturally produced by pregnant women as a response to the increased stress brought on by pregnancy.  The study showed that shortness of breath as a result of heart failure could be reduced by 17% and cardiovascular-related death was reduced form 17% to 3%.  Furthermore the study showed that Relaxin was not related to any safety concerns and resulted in only positive results; this provides future studies with the ability to implement Relaxin in multiple ways to determine the best possible method.  In line with the results of the study, it was concluded that Relaxin could potentially be an important treatment agent for acute heart failure.

As cardiovascular related problems become more prevalent and common, the need to find efficient, effective, and safe treatments grows.  Relaxin is a great option; though it may be difficult to collect large amounts for use since it is naturally produced, the fact that it is natural provides ease of use and relative freedom of methodology.

Source: http://www.medicalnewstoday.com/articles/144252.php

Tony Boyle

Sect. 502